DLD Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

DLD Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$1.26M	–	227
2022 Q2	$1.26M	Buy	+10,000	New	+$1.15M	0.09%	111

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

DLD Asset Management's KRTX Position: Q1 2024 in Review

DLD Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,200 shares — an estimated $696K sold.

DLD Asset Management first reported a position in KRTX in Q2 2022 and held it in 2 quarters. The position peaked at $1.26M in Q2 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

DLD Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
DLD Asset Management sold 2,200 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $696K.
DLD Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
DLD Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $1.26M in Q2 2022.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on DLD Asset Management's 13F filing for Q1 2024, filed 14 May 2024.